Diagnostic and Biotech

2016 New Frontiers in the European Cancer Diagnostics Market: Business Challenges, Emerging Technologies, Competitive Landscape

  • VPG340385
  • 820 Pages
  • October 2015
  • Diagnostic and Biotech
Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800.


2016 New Frontiers in the European Cancer Diagnostics Market
is VPGMarketResearchs new study of the major business opportunities emerging in the European cancer diagnostics market during the nextfive years. The report examines trends in major European countries; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.

Rationale


The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.


Geographic Coverage


France, Germany, Italy, Spain, UK


European Market Overview


- Five-year test volume and sales projections by country.


- Comprehensive market segmentation analysis, including review

of the market dynamics, structure, size, growth and major suppliers

by country.


- Estimated universe of laboratories performing cancer diagnostic testing

by country.


- Cancer statistics, etiology and recent developments.


Business Opportunities and Strategic Recommendations


- Specific new product development opportunities with potentially

significant market appeal during the next five years.


- Design criteria for new products.


- Alternative market penetration strategies.


- Potential market entry barriers and risks.


Over 200 Current and Emerging Cancer Diagnostic Test


- Biochemical Markers

- Oncogenes

- Growth Factors

- Hormones

- Colony Stimulating Factors

- Lymphokines

- Immunohistochemical Stains, and others.


- ACTH, AFP, Beta-2 Microglobulin, CA 15-3/27.29, CA 19-9, CA 125, Calcitonin, Cathepsin, CEA,

Chromogranin, Colon-Specific Antigen, Cytokeratins, Estrogen Receptor, Ferritin, Gastrin, HCG,

Insulin, Interferons, Interleukins, Lymphocyte Subtyping, Neuron-Specific Enolase, Nucleolar,

Occult Blood, Oncogenes, Pancreatic Oncofetal Antigen, Pap Smear, Parathyroid Hormone,

Progesterone Receptor, Prostatic Acid Phosphatase, Prostatic Specific Antigen, S-100 Protein,

Serotonin, Sialic Acid, Squamous Cell Carcinoma Ag, TDT, Thymidine Kinase, Thyroglobulin,

Tissue Polypeptide Antigen, and others.


Supplier Shares, Sales and Volume Forecasts


- Sales and market shares of major cancer diagnostic product

suppliers by individual test and country.


- Five-year test volume and sales forecasts

for major tumor markers by country and market segment, including:


- Hospitals

- Commercial/Private Laboratories

- Physician Offices/Group Practices


Instrumentation Review


- Analysis of major molecular diagnostic and immunodiagnostic analyzers

used for cancer testing, including their operating characteristics,

features and selling prices.


Technology Assessment


- Assessment of latest molecular diagnostic methods,

biochips/microarrays, biosensors, monoclonal antibodies, immunoassays,

chromosome analysis, IT, artificial intelligence, flow cytometry, and other technologies

and their potential applications for cancer diagnostic testing.


- Review of competing/complementing technologies, including

CT, MRI, NMR, PET and photonics spectroscopy.


- Extensive listings of companies, universities and research centers

developing new cancer diagnostic tests and detection technologies.


Competitive Strategies


- Strategic assessments ofmajor suppliers

and start-up firms developing innovative

technologies and products, including their sales,

product portfolios, marketing tactics, collaborative

arrangements, and new products in R&D.


- Companies analyzed in the report include



- Abbott

- AdnaGen

- Agilent Technologies

- Applied Gene Technologies

- Arca Biopharma

- Beckman Coulter/Danaher

- Becton Dickinson

- Biomedical Diagnostics

- bioMerieux

- Bio-Rad

- CellSearch

- Cepheid

- Correlogic Systems/Vermillion

- Decode Genetics

- Diadexus

- Diagnocure

- DiaSorin

- Eiken Chemical


- Elitech Group


- Epigenomics

- Enterix

- Enzo Biochem

- Exact Sciences

- Fujirebio

- Guided Therapeutics

- Hologic/Gen-Probe

- Kreatech/Leica

- Kyowa Medex

- Mackay Life Sciences

- Myriad Genetics

- OncoLab

- Ortho-Clinical Diagnostics

- Panacea Pharmaceuticals

- Polartechnics

- Polymedco

- PreMD

- Qiagen

- Quest Diagnostics

- Radient Pharmaceuticals

- Roche

- Scienion

- Sequenom

- Siemens Healthcare

- Takara Bio

- Targeted Diagnostics & Therapeutics

- Thermo Fisher

- Tosoh

- Veridex

- Wako Pure Chemicals

- Wallac/PE

- Zilla


Contains 820 pages and 320 tables

Please Select Format

Need More Information

Contact us
+ 1-800-910-6452
+1-971-202-1575
+91 20 66346066
--- or ---
help@bigmarketresearch.com

 

UPCOMING MARKET RESEARCH REPORTS

Global Nano Biotechnology Market (Applications, Therapeutics, Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Nano-biotechnology deals with the study of biological and biochemical applications. Increase in demand for development of new inventions in medical industry, is driving the growth of nano-biotechnology market. The U.S. ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Genotyping Market - Opportunities and Forecasts, 2015 - 2020

Genotyping is the process of studying DNA sequence to determine genetic constitution in the genotypes of living organisms, such as humans, plants, animals, and microorganisms. Human genotyping helps in determining ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

World Epigenetics Market - Opportunities and Forecasts, 2015 - 2020

Epigenetics, in the field of genetics, involves study of cellular and physiological trait variations initiated by external or ecological aspects which swipe genes on and off and affect how cells ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Veterinary Diagnostics Market (Products, Animals, Application and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Veterinary diagnostics are noninvasive methods used to identify and examine the causes of diseases in animals. Various new technologies from human diagnostics segments are being adapted for the veterinary domain. This trend is expected to continue in the future, thereby contributing to the growth of this market.

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Kinase Inhibitors Market (Types, Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Protein kinase is an enzyme that shuffles protein structure by transferring phosphate collected from ATP(Adenosine Triphosphate) . Protein kinase help in regulating variety of cell functions such as cell cycle, ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

Global Tissue Engineering and Regeneration Market (Technology, Applications and Geography) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2012 - 2020

Tissue engineering is the combination of biology medicine and engineering to create products that would improve or replace biological functions or organs. More than a decade ago, the industry introduced ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370

Read More >>

2017 © Copyright Big Market Research

View Pricing >>